Interject 15% Injection

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Ingrédients actifs:

Oxytetracycline hydrochloride

Disponible depuis:

Interchem Ireland Ltd

Code ATC:

QJ01AA06

DCI (Dénomination commune internationale):

Oxytetracycline hydrochloride

Dosage:

15 percent weight/volume

forme pharmaceutique:

Solution for injection

Type d'ordonnance:

POM: Prescription Only Medicine as defined in relevant national legislation

Groupe thérapeutique:

Cattle, Pigs, Sheep

Domaine thérapeutique:

oxytetracycline

indications thérapeutiques:

Antibacterial

Statut de autorisation:

Authorised

Date de l'autorisation:

2008-03-21

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Interject 15% Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Oxytetracycline Hydrochloride Ph. Eur.
150 mg
EXCIPIENTS
Dimethylacetamide
q.s to
1 ml (Approx. 48 %)
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Interject 15%_ is recommended in the treatment of a wide range of
common systemic, respiratory and local infections
caused by, or associated with, organisms sensitive to Oxytetracycline.
4.3 CONTRAINDICATIONS
Do not use in sheep producing milk for human consumption.
Do not use in animals with known hypersensitivity to the active
ingredient.
Do not administer intravenously.
Do not use in horses, dogs and cats.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Wash hands after use. This product contains dimethylacetamide (DMAC)
and care should be taken to prevent absorption
through the skin.
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal.
If this is not
possible, therapy should be based on local (regional, farm level)
epidemiological information about susceptibility of the
target bacteria.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_